Search
Close this search box.

“Scientific morning related to symptomatic and asymptomatic hyperuricemia and its prevalence in Iran and the world was held on 17 September 2024 at the Rheumatology Research Center of Shariati Hospital in Tehran by Kimia Ara Company

In this session, Dr. Rahimi, the scientific advisor of the group, presented the treatment protocol for symptomatic hyperuricemia (gout) according to the latest ACR guidelines, as well as the prescription of uric acid-lowering drugs in gout patients and asymptomatic hyperuricemia in high-risk patients, including those with moderate to severe kidney failure, pre-dialysis, and dialysis patients.

"Scientific morning related to symptomatic and asymptomatic hyperuricemia and its prevalence in Iran and the world was held on 17 September 2024 at the Rheumatology Research Center of Shariati Hospital in Tehran by Kimia Ara Company

This scientific morning was attended by the President of the Iranian Rheumatology Association, Dr. Mohsen Soroush, along with esteemed rheumatology professors from Shariati Hospital Research Center:

  • Dr. Tahereh Faezi
  • Dr. Farhad Gharib Doost
  • Dr. Mohsen Akhyani
  • Dr. Sasan Fallahi
  • Dr. Behrouz Yazdani
  • Dr. Shahla Abolghasemi
  • Dr. Soraya Shadmanfar
  • Dr. Maryam Moghaddasi Jahromi
  • Dr. Sara Vosoughian
  • Dr. Majid Alikhani
  • Dr. Masoumeh Akhlaghi

The fellowship of rheumatology and internal medicine residents was also held on Tuesday, 17 September 2024.

"Scientific morning related to symptomatic and asymptomatic hyperuricemia and its prevalence in Iran and the world was held on 17 September 2024 at the Rheumatology Research Center of Shariati Hospital in Tehran by Kimia Ara Company

At the end of this session, the bioequivalence studies of Febix (Febuxostat), a product of Kimia Ara Company, with Adenuric, the brand from Menarini Company, were reviewed. The results showed that Febix, according to the bioequivalence criteria approved by the FDA, is therapeutically equivalent to the original Febuxostat brand of Menarini Company.”

Similar news ...

Shahid Madani Tabriz Heart Center morning meeting

Shahid Madani Tabriz Heart Center morning meeting was held on july 23, 1400 on the role of Ticagrelor. in the treatment of Acute Coronary Syndrome and presentation of clinical studies. This meeting was held in the presence of respected professors, including: Interventionist: Dr.Separham, Dr.Ghaffari Dr.Aslan Abadi Dr.Sohrabi Electrophysiologist: Dr.Abbas Nezhad

Read more...

Scientific program of Tehran Heart Center Cath Conference

Holding the scientific program of Tehran Heart Center Cath Conference with lecture of Dr. Rahimi, (Kimiara Company’ Medical Science Liaison), on the role of Ticagloror molecule in the treatment of Acute Coronary Syndrome and review of clinical studies on Thursday, July 24, 1400. In this scientific meeting: The superior properties

Read more...
مورنینگ علمی فوریمو بیمارستان شهدای تجریش

Scientific morning of shohadaye tajrish Hospital

A scientific morning session on the new strategy in pain management with high-dose ibuprofen and also addressing osteoporosis with a new form of calcium supplement was held on Saturday, May 18, 2024, in Tajrish Hospital. In this session, Dr. Rahimi, the medical advisor of the company, presented the prevalence of

Read more...